Indapamida Retard Cinfa

Indapamide, the active ingredient in Indapamida Retard Cinfa, is a thiazide‑like diuretic presented as an extended‑release tablet for oral use. It is employed to manage hypertension and to reduce fluid overload in patients with heart‑failure‑related or renal‑disease‑related edema. It is indicated for long‑term blood pressure control and for alleviating peripheral edema, contributing to improved cardiovascular outcomes.

GNH USA supplies Indapamida Retard Cinfa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Indapamida Retard Cinfa, a thiazide‑like diuretic, is used to treat conditions involving elevated blood pressure or fluid retention.

Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk. Edema associated with heart failure: enhances urinary sodium and water excretion to decrease pulmonary and peripheral congestion. Edema associated with renal disease: promotes diuresis to manage fluid overload and improve symptom control.

Indapamida Retard Cinfa may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate cranial pain. - Fatigue: general tiredness or weakness. - Electrolyte imbalance: low potassium or sodium levels. - Increased uric acid: may precipitate gout attacks. - Gastrointestinal discomfort: nausea or abdominal cramps.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Significant electrolyte disturbances: profound hypokalemia or hyponatremia. - Acute renal failure: sudden decline in kidney function. - Allergic reactions: rash, pruritus, or angioedema. - Blood dyscrasias: agranulocytosis or leukopenia. - Photosensitivity: skin reaction to sunlight.

When prescribing Indapamida Retard Cinfa, clinicians should observe several safety considerations. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Electrolyte assessment: monitor potassium and sodium levels during therapy. - Renal function: evaluate creatinine clearance before and during treatment. - Gout history: use cautiously as uric acid may increase. - Drug interactions: review concomitant medications that affect potassium. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Indapamida Retard Cinfa can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Lithium: risk of lithium toxicity increased. - NSAIDs: may reduce diuretic efficacy and impair renal function. - ACE inhibitors/ARBs: can cause severe hypotension and renal impairment.

Moderate Interactions (Monitor Closely): - Beta‑blockers: additive blood pressure lowering effect. - Digoxin: may increase risk of arrhythmia due to electrolyte changes. - Antidiabetic agents: may enhance hypoglycemic effect.